:   ȹ ۹ 㳶  ȯ?
ָ, ī ij, Ÿ ־ α ǰ ⿬ߴ ۹ 70 3 ߴ. ֱ 㳶 Ȱ ٰ . 㳶̶  ȯ̰, ǽ 󿡴  󺹺ΰ ٸ 㳶 ǽ  ִ٣ó: Ƽ̹ũ㳶, ̹ ߰ ư 㳶 ϰ ϴ 㳶 Ѵ. Ư 㳶 ߻ϴ 찡 80% ϰ , Ǽ̳ ؼ Ÿ⵵ Ѵ. ߺ ü  2.7%, 9 شѴ. ʱ 㳶 쵵 , 㼮 Ư ȣϴ 찡 ߰ ƴ. ׳ ϰ Ÿ , Ư ʿ Ź ̴. ̿ܿ 30~60% 㳶 ȯڿ Ȳ ߻ϱ⵵ ϴµ, 㵵 ̾ 鼭 Ÿ ̴. ̷ 㳶 ִ Ȯ ʱ , 㼮 ٸ ȯ ǽϰ ˻糪 ϴٰ ߰ߵǴ 쵵 ִ ˷. 㳶 ij CT, MRI, ð ༺ (ERCP), ǰ氣 㵵(PTC) ˻縦 ִ. ̸ 㳶 ܵ , 㳶 īŸ(Capecitabine), Ÿ(Gemcitabine) Ȱ ׾ȭп 缱 ġ Ѵ. Ư ϼ 㳶 ̳ ѵ ʱ ܰ迡 㳶ε ġᰡ ϴ. 㳶 ġϴ İ Ѵ. 2023 ǥ ߾ӾϵϺ ڷῡ ϸ 2017~2021 㳶 Ÿ 㵵 5 28.9%, 30.0%, 27.7% Ȯεƴ. 5 15.9% ̴. ʱ 1⿡ ߰ 5 90% ̻ , ܰ ġᰡ ʾ 찡 . ֺ ⳪ ̵ Ŀ ߰ϰų 3~4 Ŀ ڴʰ ߰ϸ鼭 ̴. ߷ ε, ġ 5Ⱓ ġǴ 5% ϴ ˷.㼮 㳶 ߺ 衦ǰ Ĵ , ȯ ġᰡ ߿㳶 ü ִ , 㳶 ϳ 㼮 Ǵ ŭ, 㼮 ϴ ϴ ִ. Ϳ 㼮 ִ 㳶 ߺ 5~10 Ȯεƴ. 㼮 ַ ü ݷ׷  ġ鼭 µ, Ľ ¥ ⸧ ȣ  Ȱ ȴ. ݴ ̾Ʈ DZ⵵ ϴµ, ص 뷮 ̴ 쿡 ʰ ̸鼭 㼮 ִ. ߳ Ŀ ãƿ ִٰ ˷ 㼮 ֱٿ 20~30 ̿ ãƺ ִ ȯ ƴ. 㼮 ߱ ؼ ȭ Ľ ϰ, ǰ Ĵ ϴ ̴. ٸ 㼮 ߰ߵƴٰ ؼ 㳶 ̾ ƴ ŭ ġ ϰų, 㳶 ٷ ʿ . 㳶 ؾ ϴ 㼮 ȸȭ 㳶, 㳶 , շ ̻ ߰ߵ . ̶ ɼ , ̸ ϴ ȴ. ۿ ˾缺 忰 ߼ ȭ ⸸ ƼǪ ⼱õ ִ 쿡 㳶, ջ ŭ 豺 ִ. ̿ 豺 ݵ ް, ȯ ġḦ Ͽ 㳶 ֵ ؾ Ѵ.

: ȯ, ġϸ Ų?
: ġ 60%εܹ